US 12152242
CRISPR therapy
granted A61KA61K48/00
Quick answer
US patent 12152242 (CRISPR therapy) held by The Government of the United States of America as represented by the Secretary of the Deptartment of Health and Human Services expires Mon Nov 21 2044 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The Government of the United States of America as represented by the Secretary of the Deptartment of Health and Human Services
- Grant date
- Tue Nov 26 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Nov 21 2044 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 19
- CPC classes
- A61K, A61K48/00